The emerging role of linear ubiquitination in cell signaling

Science Signaling

Volumn 4, Issue 204, 2011, Pages

  Emmerich, Christoph H ^a   Schmukle, Anna C ^a   Walczak, Henning ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

BIOCHEMISTRY; CELL; HUMAN; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; MEDICAL RESEARCH; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; CELL PROLIFERATION; METABOLISM;

ANIMALS; CELL PROLIFERATION; HUMANS; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84255168970     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002187     Document Type: Review

References (105)

1. G. Chen, D. V. Goeddel, TNF-R1 signaling: A beautiful pathway. Science 296, 1634-1635 (2002).
2. M. S. Hayden, S. Ghosh, Shared principles in NF-kappaB signaling. Cell 132, 344-362 (2008).
3. A. Kovalenko, D. Wallach, If the prophet does not come to the mountain: Dynamics of signaling complexes in NF-kappaB activation. Mol. Cell 22, 433-436 (2006).
4. H. Wajant, K. Pfizenmaier, P. Scheurich, Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65 (2003).
5. B. B. Aggarwal, Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3, 745-756 (2003).
6. P. Cohen, The origins of protein phosphorylation. Nat. Cell Biol. 4, E127-E130 (2002).
7. C. M. Pickart, Back to the future with ubiquitin. Cell 116, 181-190 (2004).
8. A. Ciechanover, S. Elias, H. Heller, A. Hershko, "Covalent affinity" purification of ubiquitin-activating enzyme. J. Biol. Chem. 257, 2537-2542 (1982).
9. A. Hershko, Ubiquitin: Roles in protein modification and breakdown. Cell 34, 11-12 (1983).
10. A. Hershko, H. Heller, S. Elias, A. Ciechanover, Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J. Biol. Chem. 258, 8206-8214 (1983).
11. M. Scheffner, J. M. Huibregtse, R. D. Vierstra, P. M. Howley, The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505 (1993).
12. S. Fang, A. M. Weissman, A field guide to ubiquitylation. Cell. Mol. Life Sci. 61, 1546-1561 (2004).
13. S. Hatakeyama, M. Yada, M. Matsumoto, N. Ishida, K. I. Nakayama, U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276, 33111-33120 (2001).
14. V. Chau, J. W. Tobias, A. Bachmair, D. Marriott, D. J. Ecker, D. K. Gonda, A. Varshavsky, A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576-1583 (1989).
15. Z. J. Chen, L. J. Sun, Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33, 275-286 (2009).
16. D. Hoeller, C. M. Hecker, I. Dikic, Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 6, 776-788 (2006).
17. J. Spence, S. Sadis, A. L. Haas, D. Finley, A ubiq- uitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell. Biol. 15, 1265-1273 (1995).
18. P. Xu, D. M. Duong, N. T. Seyfried, D. Cheng, Y. Xie, J. Robert, J. Rush, M. Hochstrasser, D. Finley, J. Peng, Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133-145 (2009).
19. A. Bremm, S. M. Freund, D. Komander, Lys11- linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 17, 939-947 (2010).
20. D. Komander, F. Reyes-Turcu, J. D. Licchesi, P. Odenwaelder, K. D. Wilkinson, D. Barford, Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 10, 466-473 (2009).
21. T. Tenno, K. Fujiwara, H. Tochio, K. Iwai, E. H. Morita, H. Hayashi, S. Murata, H. Hiroaki, M. Sato, K. Tanaka, M. Shirakawa, Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells 9, 865-875 (2004).
22. R. Varadan, M. Assfalg, A. Haririnia, S. Raasi, C. Pickart, D. Fushman, Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem. 279, 7055-7063 (2004).
23. S. Virdee, Y. Ye, D. P. Nguyen, D. Komander, J. W. Chin, Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nat. Chem. Biol. 6, 750-757 (2010).
24. T. Kirisako, K. Kamei, S. Murata, M. Kato, H. Fukumoto, M. Kanie, S. Sano, F. Tokunaga, K. Tanaka, K. Iwai, A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887 (2006).
25. R. T. Baker, P. G. Board, The human ubiquitin gene family: Structure of a gene and pseudogenes from the Ub B subfamily. Nucleic Acids Res. 15, 443-463 (1987).
26. E. Özkaynak, D. Finley, A. Varshavsky, The yeast ubiquitin gene: Head-to-tail repeats encoding a polyubiquitin precursor protein. Nature 312, 663-666 (1984).
27. F. E. Reyes-Turcu, K. H. Ventii, K. D. Wilkinson, Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397 (2009).
28. O. Wiborg, M. S. Pedersen, A. Wind, L. E. Berglund, K. A. Marcker, J. Vuust, The human ubiquitin multigene family: Some genes contain multiple directly repeated ubiquitin coding sequences. EMBO J. 4, 755-759 (1985).
29. D. Finley, E. Ozkaynak, A. Varshavsky, The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell 48, 1035-1046 (1987).
30. L. Jin, A. Williamson, S. Banerjee, I. Philipp, M. Rape, Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133, 653-665 (2008).
31. H. T. Kim, K. P. Kim, F. Lledias, A. F. Kisselev, K. M. Scaglione, D. Skowyra, S. P. Gygi, A. L. Goldberg, Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 282, 17375-17386 (2007).
32. D. S. Kirkpatrick, N. A. Hathaway, J. Hanna, S. Elsasser, J. Rush, D. Finley, R. W. King, S. P. Gygi, Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol. 8, 700-710 (2006).
33. B. Gerlach, S. M. Cordier, A. C. Schmukle, C. H. Emmerich, E. Rieser, T. L. Haas, A. I. Webb, J. A. Rickard, H. Anderton, W. W. Wong, U. Nachbur, L. Gangoda, U. Warnken, A. W. Purcell, J. Silke, H. Walczak, Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011).
34. F. Ikeda, Y. L. Deribe, S. S. Skånland, B. Stieglitz, C. Grabbe, M. Franz-Wachtel, S. J. van Wijk, P. Goswami, V. Nagy, J. Terzic, F. Tokunaga, A. Androulidaki, T. Nakagawa, M. Pasparakis, K. Iwai, J. P. Sundberg, L. Schaefer, K. Rittinger, B. Macek, I. Dikic, SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641 (2011).
35. F. Tokunaga, T. Nakagawa, M. Nakahara, Y. Saeki, M. Taniguchi, S. Sakata, K. Tanaka, H. Nakano, K. Iwai, SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636 (2011).
36. S. Lim, C. Sala, J. Yoon, S. Park, S. Kuroda, M. Sheng, E. Kim, Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol. Cell. Neurosci. 17, 385-397 (2001).
37. I. Marín, A. Ferrús, Comparative genomics of the RBR family, including the Parkinson's disease-related gene parkin and the genes of the ariadne subfamily. Mol. Biol. Evol. 19, 2039-2050 (2002).
38. J. Bayle, S. Lopez, K. Iwaï, P. Dubreuil, P. De Sepulveda, The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins. FEBS Lett. 580, 2609-2614 (2006).
39. A. Ehrlund, E. H. Anthonisen, N. Gustafsson, N. Venteclef, K. Robertson Remen, A. E. Damdimopoulos, A. Galeeva, M. Pelto-Huikko, E. Lalli, K. R. Steffensen, J. A. Gustafsson, E. Treuter, E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Mol. Cell. Biol. 29, 2230-2242 (2009).
40. L. He, A. Ingram, A. P. Rybak, D. Tang, Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J. Clin. Invest. 120, 2094-2108 (2010).
41. B. S. Hostager, D. K. Fox, D. Whitten, C. G. Wilkerson, B. A. Eipper, V. P. Francone, P. B. Rothman, J. D. Colgan, HOIL-1L interacting protein (HOIP) as an NF-kappaB regulating component of the CD40 signaling complex. PLoS ONE 5, e11380 (2010).
42. J. Jung, J. M. Kim, B. Park, Y. Cheon, B. Lee, S. H. Choo, S. S. Koh, S. Lee, Newly identified tumor-associated role of human Sharpin. Mol. Cell. Biochem. 340, 161-167 (2010).
43. Y. Liang, R. E. Seymour, J. P. Sundberg, Inhibition of NF-êB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. J. Invest. Dermatol. 131, 141-149 (2011).
44. M. Nakamura, F. Tokunaga, S. Sakata, K. Iwai, Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex. Biochem. Biophys. Res. Commun. 351, 340-347 (2006).
45. Y. Tian, Y. Zhang, B. Zhong, Y. Y. Wang, F. C. Diao, R. P. Wang, M. Zhang, D. Y. Chen, Z. H. Zhai, H. B. Shu, RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation. J. Biol. Chem. 282, 16776-16782 (2007).
46. T. Xia, Y. Liang, J. Ma, M. Li, M. Gong, X. Yu, Loss-of- function of SHARPIN causes an osteopenic phenotype in mice. Endocrine 39, 104-112 (2011).
47. K. Yamanaka, H. Ishikawa, Y. Megumi, F. Tokunaga, M. Kanie, T. A. Rouault, I. Morishima, N. Minato, K. Ishimori, K. Iwai, Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5, 336-340 (2003).
48. Y. Zenke-Kawasaki, Y. Dohi, Y. Katoh, T. Ikura, M. Ikura, T. Asahara, F. Tokunaga, K. Iwai, K. Igarashi, Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol. Cell. Biol. 27, 6962-6971 (2007).
49. M. Zhang, Y. Tian, R. P. Wang, D. Gao, Y. Zhang, F. C. Diao, D. Y. Chen, Z. H. Zhai, H. B. Shu, Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res. 18, 1096-1104 (2008).
50. T. L. Haas, C. H. Emmerich, B. Gerlach, A. C. Schmukle, S. M. Cordier, E. Rieser, R. Feltham, J. Vince, U. Warnken, T. Wenger, R. Koschny, D. Komander, J. Silke, H. Walczak, Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844 (2009).
51. F. Tokunaga, S. Sakata, Y. Saeki, Y. Satomi, T. Kirisako, K. Kamei, T. Nakagawa, M. Kato, S. Murata, S. Yamaoka, M. Yamamoto, S. Akira, T. Takao, K. Tanaka, K. Iwai, Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 11, 123-132 (2009).
52. V. K. Chaugule, L. Burchell, K. R. Barber, A. Sidhu, S. J. Leslie, G. S. Shaw, H. Walden, Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30, 2853-2867 (2011).
53. D. M. Wenzel, A. Lissounov, P. S. Brzovic, R. E. Klevit, UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105-108 (2011).
54. E. W. Doss-Pepe, L. Chen, K. Madura, Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. J. Biol. Chem. 280, 16619-16624 (2005).
55. K. L. Lim, V. L. Dawson, T. M. Dawson, Parkin-mediated lysine 63-linked polyubiquitination: A link to protein inclusions formation in Parkinson's and other conformational diseases? Neurobiol. Aging 27, 524-529 (2006).
56. K. S. Inn, M. U. Gack, F. Tokunaga, M. Shi, L. Y. Wong, K. Iwai, J. U. Jung, Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol. Cell 41, 354-365 (2011).
57. S. Zhao, H. D. Ulrich, Distinct consequences of posttranslational modification by linear versus K63-linked polyubiquitin chains. Proc. Natl. Acad. Sci. U.S.A. 107, 7704-7709 (2010).
58. J. S. Thrower, L. Hoffman, M. Rechsteiner, C. M. Pickart, Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102 (2000).
59. S. Prakash, T. Inobe, A. J. Hatch, A. Matouschek, Substrate selection by the proteasome during degradation of protein complexes. Nat. Chem. Biol. 5, 29-36 (2009).
60. D. W. Banner, A. D'Arcy, W. Janes, R. Gentz, H. J. Schoenfeld, C. Broger, H. Loetscher, W. Lesslauer, Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation. Cell 73, 431-445 (1993).
61. H. Hsu, J. Huang, H. B. Shu, V. Baichwal, D. V. Goeddel, TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396 (1996).
62. H. Hsu, J. Xiong, D. V. Goeddel, The TNF receptor 1-associated protein TRADD signals cell death and NF-ê B activation. Cell 81, 495-504 (1995).
63. A. T. Ting, F. X. Pimentel-Muiños, B. Seed, RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189-6196 (1996).
64. H. B. Shu, M. Takeuchi, D. V. Goeddel, The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. U.S.A. 93, 13973-13978 (1996).
65. J. E. Vince, D. Pantaki, R. Feltham, P. D. Mace, S. M. Cordier, A. C. Schmuckle, A. J. Davidson, B. A. Callus, W. W. Wong, I. E. Gentle, H. Carter, E. F. Lee, H. Walczak, C. L. Day, D. L. Vaux, J. Silke, TRAF2 must bind to cIAPs for tumor necrosis factor (TNF) to efficiently activate NF-{κ}B and to prevent TNF-induced apoptosis. J. Biol. Chem. 284, 35906-35915 (2009).
66. P. C. Cheung, A. R. Nebreda, P. Cohen, TAB3, a new binding partner of the protein kinase TAK1. Biochem. J. 378, 27-34 (2004).
67. J. N. Dynek, T. Goncharov, E. C. Dueber, A. V. Fedorova, A. Izrael-Tomasevic, L. Phu, E. Helgason, W. J. Fairbrother, K. Deshayes, D. S. Kirkpatrick, D. Vucic, c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 4198-4209 (2010).
68. A. Kanayama, R. B. Seth, L. Sun, C. K. Ea, M. Hong, A. Shaito, Y. H. Chiu, L. Deng, Z. J. Chen, TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004).
69. H. Li, M. Kobayashi, M. Blonska, Y. You, X. Lin, Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J. Biol. Chem. 281, 13636-13643 (2006).
70. C. J. Wu, D. B. Conze, T. Li, S. M. Srinivasula, J. D. Ashwell, Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat. Cell Biol. 8, 398-406 (2006).
71. W. W. Wong, I. E. Gentle, U. Nachbur, H. Anderton, D. L. Vaux, J. Silke, RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ. 17, 482-487 (2010).
72. M. Yamamoto, T. Okamoto, K. Takeda, S. Sato, H. Sanjo, S. Uematsu, T. Saitoh, N. Yamamoto, H. Sakurai, K. J. Ishii, S. Yamaoka, T. Kawai, Y. Matsuura, O. Takeuchi, S. Akira, Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962-970 (2006).
73. M. J. Bertrand, S. Milutinovic, K. M. Dickson, W. C. Ho, A. Boudreault, J. Durkin, J. W. Gillard, J. B. Jaquith, S. J. Morris, P. A. Barker, cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689-700 (2008).
74. L. Deng, C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, Z. J. Chen, Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
75. C. K. Ea, L. Deng, Z. P. Xia, G. Pineda, Z. J. Chen, Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245-257 (2006).
76. C. S. Shi, J. H. Kehrl, Tumor necrosis factor (TNF)- induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13- Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278, 15429-15434 (2003).
77. I. E. Wertz, K. M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D. L. Boone, A. Ma, E. V. Koonin, V. M. Dixit, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699 (2004).
78. M. Xu, B. Skaug, W. Zeng, Z. J. Chen, A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol. Cell 36, 302-314 (2009).
79. H. Walczak, TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol. Rev. 244, 9-28 (2011).
80. I. Dikic, S. Wakatsuki, K. J. Walters, Ubiquitin-binding domains - from structures to functions. Nat. Rev. Mol. Cell Biol. 10, 659-671 (2009).
81. R. Döffinger, A. Smahi, C. Bessia, F. Geissmann, J. Feinberg, A. Durandy, C. Bodemer, S. Kenwrick, S. Dupuis-Girod, S. Blanche, P. Wood, S. H. Rabia, D. J. Headon, P. A. Overbeek, F. Le Deist, S. M. Holland, K. Belani, D. S. Kumararatne, A. Fischer, R. Shapiro, M. E. Conley, E. Reimund, H. Kalhoff, M. Abinun, A. Munnich, A. Israël, G. Courtois, J. L. Casanova, X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27, 277-285 (2001).
82. O. Filipe-Santos, J. Bustamante, M. H. Haverkamp, E. Vinolo, C. L. Ku, A. Puel, D. M. Frucht, K. Christel, H. von Bernuth, E. Jouanguy, J. Feinberg, A. Durandy, B. Senechal, A. Chapgier, G. Vogt, L. de Beaucoudrey, C. Fieschi, C. Picard, M. Garfa, J. Chemli, M. Bejaoui, M. N. Tsolia, N. Kutukculer, A. Plebani, L. Notarangelo, C. Bodemer, F. Geissmann, A. Israël, M. Véron, M. Knackstedt, R. Barbouche, L. Abel, K. Magdorf, D. Gendrel, F. Agou, S. M. Holland, J. L. Casanova, X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J. Exp. Med. 203, 1745-1759 (2006).
83. Y. C. Lo, S. C. Lin, C. C. Rospigliosi, D. B. Conze, C. J. Wu, J. D. Ashwell, D. Eliezer, H. Wu, Structural basis for recognition of diubiquitins by NEMO. Mol. Cell 33, 602-615 (2009).
84. S. Rahighi, F. Ikeda, M. Kawasaki, M. Akutsu, N. Suzuki, R. Kato, T. Kensche, T. Uejima, S. Bloor, D. Komander, F. Randow, S. Wakatsuki, I. Dikic, Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136, 1098-1109 (2009).
85. A. Degterev, J. Yuan, Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 9, 378-390 (2008).
86. F. Van Herreweghe, N. Festjens, W. Declercq, P. Vandenabeele, Tumor necrosis factor-mediated cell death: To break or to burst, that's the question. Cell. Mol. Life Sci. 67, 1567-1579 (2010).
87. M. Blonska, P. B. Shambharkar, M. Kobayashi, D. Zhang, H. Sakurai, B. Su, X. Lin, TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. J. Biol. Chem. 280, 43056-43063 (2005).
88. A. Devin, A. Cook, Y. Lin, Y. Rodriguez, M. Kelliher, Z. Liu, The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429 (2000).
89. M. Fotin-Mleczek, F. Henkler, A. Hausser, H. Glauner, D. Samel, A. Graness, P. Scheurich, D. Mauri, H. Wajant, Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40- induced TRAF2-mediated NF-kappaB activation. J. Biol. Chem. 279, 677-685 (2004).
90. A. Matsuzawa, P. H. Tseng, S. Vallabhapurapu, J. L. Luo, W. Zhang, H. Wang, D. A. Vignali, E. Gallagher, M. Karin, Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663-668 (2008).
91. M. Rothe, M.-G. Pan, W. J. Henzel, T. M. Ayres, D. V. Goeddel, The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252 (1995).
92. D. E. Zak, F. Schmitz, E. S. Gold, A. H. Diercks, J. J. Peschon, J. S. Valvo, A. Niemistö, I. Podolsky, S. G. Fallen, R. Suen, T. Stolyar, C. D. Johnson, K. A. Kennedy, M. K. Hamilton, O. M. Siggs, B. Beutler, A. Aderem, Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc. Natl. Acad. Sci. U.S.A. 108, 11536-11541 (2011).
93. P. H. Tseng, A. Matsuzawa, W. Zhang, T. Mino, D. A. Vignali, M. Karin, Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75 (2010).
94. J. Gautheron, G. Courtois, "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin- mediated control of NF-kappaB activation. Cell. Mol. Life Sci. 67, 3101-3113 (2010).
95. C. Culver, A. Sundqvist, S. Mudie, A. Melvin, D. Xirodimas, S. Rocha, Mechanism of hypoxia-induced NF-kappaB. Mol. Cell. Biol. 30, 4901-4921 (2010).
96. F. Ikeda, N. Crosetto, I. Dikic, What determines the specificity and outcomes of ubiquitin signaling? Cell 143, 677-681 (2010).
97. L. M. Duncan, S. Piper, R. B. Dodd, M. K. Saville, C. M. Sanderson, J. P. Luzio, P. J. Lehner, Lysine- 63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25, 1635-1645 (2006).
98. E. Varfolomeev, T. Goncharov, A. V. Fedorova, J. N. Dynek, K. Zobel, K. Deshayes, W. J. Fairbrother, D. Vucic, c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)- induced NF-kappaB activation. J. Biol. Chem. 283, 24295-24299 (2008).
99. Z. P. Xia, L. Sun, X. Chen, G. Pineda, X. Jiang, A. Adhikari, W. Zeng, Z. J. Chen, Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114-119 (2009).
100. F. E. Reyes-Turcu, J. R. Horton, J. E. Mullally, A. Heroux, X. Cheng, K. D. Wilkinson, The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 124, 1197-1208 (2006).
101. Y. Kulathu, M. Akutsu, A. Bremm, K. Hofmann, D. Komander, Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nat. Struct. Mol. Biol. 16, 1328-1330 (2009).
102. Y. Sato, A. Yoshikawa, H. Mimura, M. Yamashita, A. Yamagata, S. Fukai, Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by tandem UIMs of RAP80. EMBO J. 28, 2461-2468 (2009).
103. S. K. Nanda, R. K. C. Venigalla, A. Ordureau, J. C. Patterson-Kane, D. W. Powell, R. Toth, J. S. C. Arthur, P. Cohen, Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J. Exp. Med. 208, 1215-1228 (2011).
104. E. Laplantine, E. Fontan, J. Chiaravalli, T. Lopez, G. Lakisic, M. Véron, F. Agou, A. Israël, NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 28, 2885-2895 (2009).
105. M. Gyrd-Hansen, M. Darding, M. Miasari, M. M. Santoro, L. Zender, W. Xue, T. Tenev, P. C. da Fonseca, M. Zvelebil, J. M. Bujnicki, S. Lowe, J. Silke, P. Meier, IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat. Cell Biol. 10, 1309-1317 (2008).